Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABN AMRO Life Sciences Capital
Amsterdam, Netherlands
- Ownership
- Private
- Development stage
- Other
01
Overview
ABN AMRO Life Sciences Capital was the dedicated venture capital arm of ABN AMRO Bank, specializing in investments within the life sciences, biotechnology, and medical technology sectors. Based in the Netherlands, the firm focused on providing capital to high-growth companies across Europe and North America. In 2006, the investment team successfully completed a management buy-out from ABN AMRO to establish Forbion Capital Partners, an independent venture capital firm. During its tenure, the group was instrumental in funding several successful biotech startups that later achieved significant exits through IPOs or acquisitions.
- Industry
- Investors
Beyond the preview
Go deeper on ABN AMRO Life Sciences Capital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABN AMRO Life Sciences Capital.